GMRS 6495-1-001Recalls & reported problems
Howmedica Osteonics Corp. · Proximal Femoral Component · Class 2 · Implant
All models of GMRS (32)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 07613327048704), received between Nov 9, 2017 and Feb 6, 2025 — classified as 4 injuries, 1 malfunction.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).
2 other recalls cover devices cleared under the same FDA submission (K023087, K222056, K233261, K241716); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information2
- Adverse Event Without Identified Device or Use Problem1
- Device Dislodged or Dislocated1
- Packaging Problem1
Patient problems
- Unspecified Infection2
- Injury1
- Joint Dislocation1
- Muscle/Tendon Damage1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryFeb 6, 2025Insufficient Device Problem Information; Insufficient Device Problem Information
IT APPEARS THAT THE PATIENT RECEIVED A GMRS HIP REPLACEMENT IN MID-2024. THE PATIENT COMPLAINS OF MUSCLE PAIN AND MUSCLE TENSION, AMONG OTHER ISSUES. THE PATIENT IS CONCERNED THAT HE IS ALLERGIC TO THE IMPLAN.T
Patient problems: Muscle/Tendon Damage
MAUDE report 21320256 ↗InjuryFeb 29, 2024Device Dislodged or Dislocated; Device Dislodged or Dislocated
REVISION RTHA- DISSOCIATED CONSTRAINED LINER FROM CUP. REVISING TO ANOTHER CONSTRAINED LINER AND CHANGING THE PROXIMAL FEMUR COMPONENT STANDARD TO ANTEVERTED COMPONENT.
Patient problems: Joint Dislocation
MAUDE report 18809583 ↗InjuryJun 22, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT'S LEFT TOTAL FEMUR WAS REVISED. AS REPORTED: "PT. PRESENTED WITH SYMPTOMS OF AN ACUTE INFECTION, LAB-WORK AND IMAGING DETERMINED THE PATIENT HAD AN ACUTE INFECTION OF THE LEFT-THIGH. SURGEON PERFORMED AN I&D OF THE PATIENT¿S THIGH AND HIP AND DETERMINED IT¿D BE BEST TO EXTEND THE INCISION DOWN TO THE KNEE TO ENSURE PROPER I&D OF THE PATIENT¿S GMRS TOTAL-FEMUR CONSTRUCT. SURGEON REPLACED ALL COMPONENTS LISTED ON THE ORIGINAL SURGERY-SHEET EXCEPT FOR THE ALL-POLY TIBIAL COMPONENT. IT WAS CONSIDERED WELL FIXED AND LEFT IN-SITU. NO COMPLAINTS FILED AGAINST THE IMPLANTS THEMSELVES."
Patient problems: Unspecified Infection
MAUDE report 14780547 ↗InjuryJan 24, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
IT WAS REPORTED THROUGH THE SUBMISSION OF A REVISION IMPLANT SHEET THAT PATIENT'S RIGHT KNEE WAS REVISED. A NOTE AT THE BOTTOM OF THE SHEET REPORTS "REVISED FOR INSTABILITY AND POSSIBLE INFECTION". AN MRH KNEE CONSTRUCT WAS REVISED TO AN MRH/ GMRS KNEE CONSTRUCT.
Patient problems: Injury; Unspecified Infection
MAUDE report 9628284 ↗MalfunctionNov 9, 2017Packaging Problem; Packaging Problem
IT WAS REPORTED THAT IN REVISING PATIENT'S RIGHT HIP, REP DISCOVERED THAT THE INNER PACKAGING OF THE INTENDED IMPLANT WAS COMPROMISED. THE OUTER BOX AND OUTER PACKAGING WERE REPORTED TO BE INTACT AND IN GOOD CONDITION. SURGEON ELECTED TO NOT USE THE IMPLANT DUE TO STERILITY CONCERNS AND INSTEAD REVISED PATIENT TO A PROXIMAL FEMORAL DEVICE WITH A TROCHANTER. AS THIS IMPLANT IS LARGER THAN THE INTENDED IMPLANT, SURGEON REPORTED DIFFICULTY IN CLOSING THE WOUND AS A SOFT TISSUE ENVELOPE HAD FORMED AROUND THE ORIGINAL IMPLANT. REP REPORTED A SURGICAL DELAY OF APPROXIMATELY 3 MINUTES.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7014248 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K023087, K222056, K233261, K241716. One submission often covers many models, so check the product and lot details in each record.
- Z-2732-2024 · Aug 5, 2024 · Open, ClassifiedCustom Made Device - GMRS EXTENSION Piece 40MM LEFT, 35 Deg EXT Rotated Tabs (Patient Specific); Catalog Number: C-MM100434-00;
- Z-2624-2010 · May 5, 2005 · TerminatedGMRS Extension Piece, 60 mm; Sterile Stryker Howmedica Osteonics; Howmedica Internation S. de. R.L. Limerick, Ireland. The Global Modular Replacement System is intended to be used
Other Prosthesis, hip, semi-constrained, metal/polymer, cemented devices
- NA 1365-51-000Depuy (Ireland) · Prosthesis, hip, semi-constrained, metal/polymer, cemented753 reports
- NA 1365-50-000Depuy (Ireland) · Prosthesis, hip, semi-constrained, metal/polymer, cemented412 reports
- ARTICUL/EZE 1365-21-000Depuy (Ireland) · Prosthesis, hip, semi-constrained, metal/polymer, cemented1 recall280 reports
- ARTICUL/EZE 1365-11-000Depuy (Ireland) · Prosthesis, hip, semi-constrained, metal/polymer, cemented1 death262 reports
- LFIT 6260-9-236Howmedica Osteonics Corp. · Prosthesis, hip, semi-constrained, metal/polymer, cemented256 reports
- PINNACLE GRIPTION 1217-32-052Depuy Orthopaedics, Inc. · Prosthesis, hip, semi-constrained, metal/polymer, cemented2 deaths239 reports
- ELEOS™ 25002111EOnkos Surgical, Inc. · Prosthesis, hip, semi-constrained, metal/polymer, cemented3 deaths230 reports
- Novation 130-36-52Exactech, Inc. · Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented2 recalls124 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page